Skip to main content
An official website of the United States government

U.S. and U.K. Convene Bilateral Scientific Cancer Summit

, by Center for Global Health Staff

Cancer Research UK, Medical Research Council in the UK, and National Cancer Institute logos

On November 13 and 14, 2021, the United States and the United Kingdom will jointly convene a scientific cancer summit. This scientific meeting is an initial step toward carrying out a vision set forth by the two countries in a Joint Statement, issued ahead of the G7 Summit in June 2021, “to share ideas and identify opportunities for collaboration to accelerate advances in lifesaving approaches to cancer, which remains a leading cause of death worldwide.” 

The “US-UK Bilateral Scientific Summit” will bring together a small group of world-leading cancer researchers, clinicians, patient advocates, and industry representatives from both countries. The attendees will begin the process of identifying transformative research challenges and ways to resolve barriers to progress to accelerate and fundamentally change our understanding of cancer, our approach to it, and ultimately the experience of people with cancer and their families.  
The US National Cancer Institute is working in partnership with the Medical Research Council (MRC) and Cancer Research UK (CRUK) to organize the summit. Following the event, the three organizations will hold a series of engagement activities with the broader cancer community to help shape and prioritize outputs. Recommendations will be shared with the respective government offices to support announcements at a follow-up leaders’ summit, which is expected to be held in Spring 2022. Read more about the Summit on UK Research and Innovation's website

< Older Post

CGH Supports 8 New Supplemental Projects Studying COVID-19 and Cancer in LMICs

Newer Post >

NCI Center for Global Health Awards 6 Administrative Supplements in Global Survivorship Research

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “U.S. and U.K. Convene Bilateral Scientific Cancer Summit was originally published by the National Cancer Institute.”